Patents by Inventor Bertil Bengt Samuelsson

Bertil Bengt Samuelsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidine substituted macrocyclic HCV inhibitors
    Patent number: 8937080
    Abstract: Compounds of the formula I: including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: January 20, 2015
    Assignees: Medivir AB, Janssen R&D Ireland
    Inventors: Pierre Jean-Marie Bernard Raboisson, Anna Karin Gertrud Linnea Belfrage, Björn Olof Classon, Karin Charlotta Lindquist, Karl Magnus Nilsson, Åsa Annica Kristina Rosenquist, Bertil Bengt Samuelsson, Horst Jürgen Wähling
  • PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS
    Publication number: 20100113440
    Abstract: Compounds of the Formula (I) including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient.
    Type: Application
    Filed: February 8, 2008
    Publication date: May 6, 2010
    Applicant: Tibotec Pharmaceuticals, Ltd.
    Inventors: Anna Karin Gertrud Linnea Belfrage, Björn Olof Classon, Karin Charlotta Lindquist, Karl Magnus Nilsson, Pierre Jean-Marie Bernard Raboisson, Åsa Annica Kristina Rosenquist, Bertil Bengt Samuelsson, Horst Jürgen Wähling